Alignment Healthcare (ALHC) CEO John Kao Sells 557,870 Shares

What Happened

• John E. Kao, CEO of Alignment Healthcare (ALHC), sold a total of 557,870 shares in two open-market transactions: 172,600 shares on 2026-09-10 for $12.96 (total $2,236,447) and 385,270 shares on 2026-09-11 for $12.68 (total $4,885,224). Combined proceeds were about $7.12 million. These were sales (not purchases) and were executed under a Rule 10b5-1 trading plan.

Key Details

• Transaction dates and reported amounts:
  • 2026-09-10 — 172,600 shares; reported weighted-average $12.96; total $2,236,447. (Footnote F5: shares sold across prices ranging $12.394–$13.17.)
  • 2026-09-11 — 385,270 shares; reported weighted-average $12.68; total $4,885,224. (Footnote F2: shares sold across prices ranging $12.71–$13.21.)
• Combined shares sold: 557,870; combined proceeds ≈ $7.12M.
• Shares owned after the transactions: not disclosed in the excerpt provided (see full Form 4 for post-transaction holdings).
• Notable footnotes:
  • F1: 10b5-1 plan adopted 05/27/2026 (preplanned sales).
  • F3: Some securities are held by JEK Trust (Mr. Kao is trustee).
  • F4: Some sales may have been to cover tax withholding for RSU vesting (non-discretionary).
  • F2/F5: Reported prices are weighted averages; full per-price breakdown available on request per filing.
• Filing timeliness: Form 4 was filed 2026-09-11 for transactions on 2026-09-10 and 2026-09-11 — no late filing indicated.

Context

• These were open-market sales executed under a 10b5-1 plan or to satisfy tax withholding; such sales are commonly preplanned or administrative and do not necessarily signal a change in the insider’s view of the company. Retail investors should consider this as disclosure of insider liquidity rather than an explicit vote of confidence or concern. For full holdings, exact per-trade prices, and any allocation between personal and trust-held shares, consult the complete Form 4 (accession 0001628280-26-061620).